30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

Mural Oncology PLC (MURA)

Track

Stock chart
Ticker: MURA Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Goodman Vicki L
Officer
2 sales — total 20,950 USD
Proposed sale 10 Nov 2025
Value US$4,913,941.45 | Price 317.61 | Shares 35,916
Planned sale 10 Nov 2025
Value US$1,252,243.82 | Price 470.91 | Shares 54,217
Proposed sale 3 Nov 2025
Value US$3,932,173.80 | Price 73.09 | Shares 74,676
Planned sale 3 Nov 2025
Value US$4,211,099.86 | Price 124.47 | Shares 85,507
Planned sale 22 Jul 2025
Value US$6,378.56 | Price 2.48 | Shares 2,572
Proposed sale 22 Jul 2025
Value US$6,404.00 | Price 2.49 | Shares 2,572
Planned sale 18 Jul 2025
Value US$5,351.84 | Price 2.48 | Shares 2,158
Proposed sale 7 Jul 2025
Value US$30,469.00 | Price 2.43 | Shares 12,513
Planned sale 7 Jul 2025
Value US$30,475.39 | Price 2.43 | Shares 12,531
Proposed sale 5 Mar 2025
Value US$5,039.00 | Price 3.43 | Shares 1,469
Planned sale 5 Mar 2025
Value US$5,068.05 | Price 3.45 | Shares 1,469
Proposed sale 4 Mar 2025
Value US$14,491.00 | Price 3.36 | Shares 4,313
Planned sale 4 Mar 2025
Value US$14,491.68 | Price 3.36 | Shares 4,313
Planned sale 4 Mar 2025
Value US$4,240.32 | Price 3.36 | Shares 1,262
Planned sale 24 Feb 2025
Value US$51,293.54 | Price 3.89 | Shares 13,186
Proposed sale 24 Feb 2025
Value US$53,271.00 | Price 4.04 | Shares 13,186
Planned sale 23 Dec 2024
Value US$8,354.85 | Price 3.27 | Shares 2,555
Proposed sale 23 Dec 2024
Value US$8,304.00 | Price 3.25 | Shares 2,555
Planned sale 17 Dec 2024
Value US$9,394.20 | Price 3.40 | Shares 2,763
Proposed sale 7 Nov 2024
Value US$16,870.00 | Price 3.33 | Shares 5,069
Planned sale 7 Nov 2024
Value US$16,879.77 | Price 3.33 | Shares 5,069
Proposed sale 31 Oct 2024
Value US$25,306.00 | Price 3.41 | Shares 7,421
Planned sale 31 Oct 2024
Value US$25,305.61 | Price 3.41 | Shares 7,421
Buy 14 Aug 2024
Value US$32,071.00 | Price 3.21 | Shares 10,000
Planned sale 18 Jul 2024
Value US$7,355.37 | Price 3.41 | Shares 2,157
Proposed sale 8 Jul 2024
Value US$36,469.05 | Price 2.91 | Shares 12,531
Planned sale 8 Jul 2024
Value US$36,465.21 | Price 2.91 | Shares 12,531
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2025-11-10 2025-11-10 PrS Proposed sale
Goodman Vicki L

Officer

Officer
35,916
317.61
US$4,913,941 		35,916 317.61 US$4,913,941
2025-11-10 2025-11-10 PlS Planned sale
Goodman Vicki L

Chief Medical Officer

Officer
54,217 -16.0%
470.91
US$1,252,244 		54,217 -16.0% 470.91 US$1,252,244
2025-11-10 2025-11-03 PrS Proposed sale
Cutler Adam D.

Officer

Officer
74,676
73.09
US$3,932,174 		74,676 73.09 US$3,932,174
2025-11-10 2025-11-03 PlS Planned sale
Cutler Adam D.

Chief Financial Officer

Officer
7,148 -6.7%
2.09
US$14,939 		7,148 -6.7% 2.09 US$14,939
2025-07-23 2025-07-22 PlS Planned sale
Keson-Brookes Maiken

See Remarks

Officer
2,572 -3.6%
2.48
US$6,379 		2,572 -3.6% 2.48 US$6,379
2025-07-22 2025-07-22 PrS Proposed sale
Maiken Keson-Brookes

CLO
2,572
2.49
US$6,404 		2,572 2.49 US$6,404
2025-07-22 2025-07-18 PlS Planned sale
Keson-Brookes Maiken

See Remarks

Officer
2,158 -2.9%
2.48
US$5,352 		2,158 -2.9% 2.48 US$5,352
2025-07-09 2025-07-07 PrS Proposed sale
Loew Caroline

Officer; Director

Executive Director
12,513
2.43
US$30,469 		12,513 2.43 US$30,469
2025-07-09 2025-07-07 PlS Planned sale
Loew Caroline

Chief Executive Officer

Executive Director
12,531 -4.1%
2.43
US$30,475 		12,531 -4.1% 2.43 US$30,475
2025-03-05 2025-03-05 PrS Proposed sale
Maiken Keson-Brookes

CLO
1,469
3.43
US$5,039 		1,469 3.43 US$5,039
2025-03-05 2025-03-05 PlS Planned sale
Keson-Brookes Maiken

See Remarks

Officer
1,469 -2.0%
3.45
US$5,068 		1,469 -2.0% 3.45 US$5,068
2025-03-05 2025-03-04 PrS Proposed sale
Loew Caroline

Officer; Director

Executive Director
4,313
3.36
US$14,491 		4,313 3.36 US$14,491
2025-03-05 2025-03-04 PlS Planned sale
Keson-Brookes Maiken

See Remarks

Officer
1,262 -1.7%
3.36
US$4,240 		1,262 -1.7% 3.36 US$4,240
2025-03-05 2025-03-04 PlS Planned sale
Loew Caroline

Chief Executive Officer

Executive Director
4,313 -1.4%
3.36
US$14,492 		4,313 -1.4% 3.36 US$14,492
2025-02-25 2025-02-24 PlS Planned sale
Goodman Vicki L

Chief Medical Officer

Officer
13,186 -19.4%
3.89
US$51,294 		13,186 -19.4% 3.89 US$51,294
2025-02-24 2025-02-24 PrS Proposed sale
Vicki Goodman

Officer

Officer
13,186
4.04
US$53,271 		13,186 4.04 US$53,271
2024-12-26 2024-12-23 PlS Planned sale
Keson-Brookes Maiken

See Remarks

Officer
2,555 -5.8%
3.27
US$8,355 		2,555 -5.8% 3.27 US$8,355
2024-12-23 2024-12-23 PrS Proposed sale
Maiken Keson-Brookes

CLO
2,555
3.25
US$8,304 		2,555 3.25 US$8,304
2024-12-18 2024-12-17 PlS Planned sale
Loew Caroline

Chief Executive Officer

Executive Director
2,763 -1.1%
3.40
US$9,394 		2,763 -1.1% 3.40 US$9,394
2024-11-08 2024-11-07 PrS Proposed sale
Goodman Vicki L

Officer

Officer
5,069
3.33
US$16,870 		5,069 3.33 US$16,870
2024-11-08 2024-11-07 PlS Planned sale
Goodman Vicki L

Chief Medical Officer

Officer
5,069 -6.9%
3.33
US$16,880 		5,069 -6.9% 3.33 US$16,880
2024-11-01 2024-10-31 PrS Proposed sale
Cutler Adam D.

Officer

Officer
7,421
3.41
US$25,306 		7,421 3.41 US$25,306
2024-11-01 2024-10-31 PlS Planned sale
Cutler Adam D.

Chief Financial Officer

Officer
7,421 -9.4%
3.41
US$25,306 		7,421 -9.4% 3.41 US$25,306
2024-08-15 2024-08-14 B Purchase
1.9
ALTSCHULLER Susan
Non-Executive Director
10,000 +inf%
3.21
US$32,071 		10,000 +inf% 3.21 US$32,071
2024-07-18 2024-07-18 PlS Planned sale
Keson-Brookes Maiken

See Remarks

Officer
2,157 -4.7%
3.41
US$7,355 		2,157 -4.7% 3.41 US$7,355
2024-07-08 2024-07-08 PrS Proposed sale
Loew Caroline

Officer; Director

Executive Director
12,531
2.91
US$36,469 		12,531 2.91 US$36,469
2024-07-08 2024-07-08 PlS Planned sale
Loew Caroline

Chief Executive Officer

Executive Director
12,531 -5.0%
2.91
US$36,465 		12,531 -5.0% 2.91 US$36,465
Explore more

More insider trading research around Mural Oncology PLC

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America